These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32727533)

  • 1.
    Jiang P; Purtskhvanidze K; Kandzia G; Neumann D; Luetzen U; Siebert FA; Roider J; Dunst J
    Radiat Oncol; 2020 Jul; 15(1):183. PubMed ID: 32727533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ruthenium brachytherapy for uveal melanomas: Factors affecting the development of radiation complications.
    Pagliara MM; Tagliaferri L; Azario L; Lenkowicz J; Lanza A; Autorino R; Caputo CG; Gambacorta MA; Valentini V; Blasi MA
    Brachytherapy; 2018; 17(2):432-438. PubMed ID: 29275868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
    Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
    Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (106)Ru plaque brachytherapy for uveal melanoma: factors associated with local tumor recurrence.
    Barker CA; Francis JH; Cohen GN; Marr BP; Wolden SL; McCormick B; Abramson DH
    Brachytherapy; 2014; 13(6):584-90. PubMed ID: 24880583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uveal melanoma treated with iodine-125 episcleral plaque: an analysis of dose on disease control and visual outcomes.
    Perez BA; Mettu P; Vajzovic L; Rivera D; Alkaissi A; Steffey BA; Cai J; Stinnett S; Dutton JJ; Buckley EG; Halperin E; Marks LB; Mruthyunjaya P; Kirsch DG
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):127-36. PubMed ID: 24613808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review.
    Le BHA; Kim JW; Deng H; Rayess N; Jennelle RL; Zhou SY; Astrahan MA; Berry JL
    Brachytherapy; 2018; 17(6):981-989. PubMed ID: 30082188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18 years' experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma.
    van Ginderdeuren R; van Limbergen E; Spileers W
    Br J Ophthalmol; 2005 Oct; 89(10):1306-10. PubMed ID: 16170122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas.
    Tarmann L; Wackernagel W; Ivastinovic D; Schneider M; Winkler P; Langmann G
    PLoS One; 2017; 12(8):e0183833. PubMed ID: 28859118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: a mono-institutional experience.
    Perri P; Fiorica F; D'Angelo S; Lamberti G; Parmeggiani F; Martini A; Carpenteri F; Colosimo C; Micucci M; Perazzini L; De Gugliemo E; Berretta M; Sebastiani A; Cartei F
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1919-24. PubMed ID: 23242717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A choice of radionuclide: Comparative outcomes and toxicity of ruthenium-106 and iodine-125 in the definitive treatment of uveal melanoma.
    Takiar V; Voong KR; Gombos DS; Mourtada F; Rechner LA; Lawyer AA; Morrison WH; Garden AS; Beadle BM
    Pract Radiat Oncol; 2015; 5(3):e169-e176. PubMed ID: 25423888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease control and toxicity outcomes using ruthenium eye plaque brachytherapy in the treatment of uveal melanoma.
    Takiar V; Gombos DS; Mourtada F; Rechner LA; Lawyer AA; Morrison WH; Garden AS; Beadle BM
    Pract Radiat Oncol; 2014; 4(4):e189-94. PubMed ID: 25012839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients.
    Shields CL; Shields JA; Cater J; Gündüz K; Miyamoto C; Micaily B; Brady LW
    Arch Ophthalmol; 2000 Sep; 118(9):1219-28. PubMed ID: 10980767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
    Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM
    Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
    Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodine Plaque Brachytherapy a Customized Conservative Approach to the Management of Medium/Large-sized Uveal Melanoma.
    Laliscia C; Perrone F; Cresti F; Guido F; Fuentes T; Trippa C; Paiar F; Pellegrini G; Ebert FG
    In Vivo; 2024; 38(4):1814-1822. PubMed ID: 38936895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ruthenium-106 plaque brachytherapy for uveal melanoma.
    Tarmann L; Wackernagel W; Avian A; Mayer C; Schneider M; Winkler P; Langmann G
    Br J Ophthalmol; 2015 Dec; 99(12):1644-9. PubMed ID: 25979763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma.
    Summanen P; Immonen I; Kivelä T; Tommila P; Heikkonen J; Tarkkanen A
    Br J Ophthalmol; 1996 Aug; 80(8):732-9. PubMed ID: 8949719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retina dose as a predictor for visual acuity loss in
    Heilemann G; Fetty L; Blaickner M; Nesvacil N; Zehetmayer M; Georg D; Dunavoelgyi R
    Radiother Oncol; 2018 Jun; 127(3):379-384. PubMed ID: 29452902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.